The advantages of switch to subcutaneous bortezomib in the real life

Silvia Mangiacavalli, Federica Cocito, Virginia Valeria Ferretti, Maya Ganzetti, Claudio Salvatore Cartia, Alessandro Corso

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1505-1507
Number of pages3
JournalLeukemia and Lymphoma
Issue number6
Publication statusPublished - Jun 2018


  • Administration, Intravenous
  • Antineoplastic Agents/administration & dosage
  • Bortezomib/administration & dosage
  • Humans
  • Injections, Subcutaneous
  • Multiple Myeloma/diagnosis
  • Patient Compliance
  • Patient Satisfaction
  • Treatment Outcome

Cite this